Responses
Scientific Abstracts
Poster Presentations
Posters
Epidemiology, health services and outcome research
FRI0405 Simultaneously forecasting burden of illness and cost-effectiveness: The case of tumour necrosis factor-alpha antagonist for ankylosing spondylitis in the dutch society
Compose a Response to This Article
Other responses
No responses have been published for this article.